Medical Device Network on MSN
Alcon spends up to $200M to co-develop customisable cataract lenses with RxSight
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...
GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...
Please provide your email address to receive an email when new articles are posted on . MILAN — In difficult eyes or eyes with comorbidities in which diffractive trifocal IOLs are not an option, the ...
Alcon is the leading manufacturer of intraocular lenses. Of the 20 million cataract procedures conducted globally each year, only 4% of patients receive PC-IOLs. Now, with a lens that offers a visual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results